用于证实膝关节和髋关节置换术保险覆盖政策的低水平证据
该研究检查美国九家最大商业保险公司的膝关节和髋关节置换术覆盖政策中引用的参考文献,评估这些文献能否证明术前授权标准。在824篇参考文献中,仅450篇(54.6%)与初次全膝关节或全髋置换术相关;与非手术治疗相关的84篇文献中仅16篇(19.1%)为I至III级证据,仅4篇专门测试非手术方式的疗效。作者认为现行术前授权标准缺乏证据支持。
要点
- 九家最大商业保险公司有公开的膝关节和髋关节置换术覆盖政策。
- 824篇参考文献中仅450篇(54.6%)与初次全膝关节或全髋置换术相关。
- 与非手术治疗相关的84篇文献中仅16篇(19.1%)为I至III级证据。
核心结论
- 现行膝关节和髋关节置换术保险覆盖政策中的术前授权标准缺乏证据支持。
- 作者认为接受全关节置换术的患者将受益于以循证医学为基础推荐的术前授权标准,而目前并非如此。
研究设计与样本
- 研究识别美国最大的私人商业保险公司,其中九家有公开可获取的膝关节和髋关节置换术覆盖政策。
- 提取手术批准的覆盖标准及相应参考文献,由评审者按证据等级、参考文献类型及与三项标准分组的关系进行分级。
主要发现
- 在824篇参考文献中,仅450篇(54.6%)与初次全膝关节和全髋关节置换术相关。
- 824篇参考文献中,259篇(31.4%)包含与骨关节炎诊断相关的信息,84篇(10.2%)与非手术治疗相关,107篇(13.0%)与排除标准相关。
- 与非手术治疗相关的84篇参考文献中,仅16篇(19.1%)为I至III级证据。
- 在所有与非手术治疗相关的参考文献中,仅4篇专门测试非手术方式的疗效,占全部参考文献的0.5%。
关键数值与推荐
- 识别出三项覆盖标准:(1)骨关节炎诊断;(2)非手术治疗(如术前物理治疗、非甾体抗炎药等);(3)排除标准(如体重指数阈值<40)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Access to total knee arthroplasty (TKA) or total hip arthroplasty (THA) has become increasingly regulated by health care insurance providers that require specific criteria be met prior to authorizing surgery as medically necessary. The purpose of this study was to examine references from coverage policies and assess whether they justify the presurgery criteria mandated by insurance providers for approval of total joint arthroplasty in patients who have symptomatic knee and hip degenerative disease. METHODS: The largest private commercial insurance providers in the United States were identified, of which nine had publicly accessible coverage policies for TKA and THA. Coverage criteria for procedural approval and respective references were retrieved. There are three coverage criteria identified: (1) diagnosis of osteoarthritis, (2) nonsurgical treatment (e.g., preoperative physical therapy, nonsteroidal anti-inflammatories, etc.), and (3) exclusion criteria (e.g., body mass index thresholds < 40). Reviewers graded references cited in coverage policies by level of evidence, type of reference, and relationship to the three criteria groupings. RESULTS: In total, out of 824 references, only 450 (54.6%) references were relevant to primary TKA and THA. Of the 824, 259 (31.4%) contained information pertinent to the diagnosis of osteoarthritis, 84 (10.2%) to nonsurgical treatment, and 107 (13.0%) to exclusion criteria. Of the 84 references relevant to nonsurgical treatment, only 16 (19.1%) had a level of evidence I to III. Among all references related to nonsurgical treatment, only four specifically tested the efficacy of nonoperative modalities, representing 0.5% of all references. CONCLUSIONS: Current prior authorization criteria found in insurance coverage policies for TKA and THA are unsubstantiated. Patients presenting for total joint arthroplasty would benefit from prior authorization criteria with recommendations grounded in evidence-based medicine. This is currently not the case.
引用
- Telang SS, Telang S, Aron A, et al. Low-Level Evidence Used to Substantiate Insurance Coverage Policies for Knee and Hip Arthroplasty. J Arthroplasty. 2025. PMID: 40349868. doi:10.1016/j.arth.2025.04.087
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。